Our observations are consistent with previous reports indicating the limited ability of PSA to clearly distinguish BPH from prostate cancer and the lack of a strong, consistent correlation between PSA levels and Gleason score in some cohorts [37,39]. This evidence concerns the gene KLK3 and prostate carcinoma.